Home page Home page

Rilutek
riluzole

Package leaflet: Information for the user


RILUTEK 50 mg film-coated tablets

Riluzole


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.


What is in this leaflet

  1. What RILUTEK is and what it is used for

  2. What you need to know before you take RILUTEK

  3. How to take RILUTEK

  4. Possible side effects

  5. How to store RILUTEK

  6. Contents of the pack and other information


  1. What RILUTEK is and what it is used for What RILUTEK is

    The active substance in RILUTEK is riluzole which acts on the nervous system.


    What RILUTEK is used for


    RILUTEK is used in patients with amyotrophic lateral sclerosis (ALS).


    ALS is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness, muscle waste and paralysis.


    The destruction of nerve cells in motor neurone disease may be caused by too much glutamate (a chemical messenger) in the brain and spinal cord. RILUTEK stops the release of glutamate and this may help in preventing the nerve cells being damaged.


    Please consult your doctor for more information about ALS and the reason why this medicine has been prescribed for you.


  2. What you need to know before you take RILUTEK Do not take RILUTEK

    • if you are allergic to riluzole or any of the other ingredients of this medicine (listed in section 6),

    • if you have any liver disease or increased blood levels of some enzymes of the liver (transaminases),

    • if you are pregnant or breast-feeding.

      Warnings and precautions

      Talk to your doctor before taking RILUTEK:

    • if you have any liver problems: yellowing of your skin or the white of your eyes (jaundice), itching all over, feeling sick, being sick

    • if your kidneys are not working very well

    • if you have any fever: it may be due to a low number of white blood cells which can cause an increased risk of infection

      If any of the above applies to you, or if you are not sure, tell your doctor who will decide what to do.


      Children and adolescents

      If you are less than 18 years of age, the use of RILUTEK is not recommended because there is no information available in this population.


      Other medicines and RILUTEK

      Tell your doctor if you are taking, have recently taken or might take any other medicines.


      Pregnancy, breast-feeding and fertility

      You MUST NOT take RILUTEK if you are or think you may be pregnant, or if you are breast-feeding.


      If you think you may be pregnant, or if you intend to breast-feed, ask your doctor for advice before taking RILUTEK.


      Driving and using machines

      You can drive or use any tools or machines, unless you feel dizzy or lightheaded after taking this medicine.


      RILUTEK contains sodium

      This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium free”.


  3. How to take RILUTEK


    Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.


    The recommended dose is one tablet, twice a day.

    The tablets should be taken by mouth, every 12 hours, at the same time of the day each day (e.g. in the morning and evening).


    If you take more RILUTEK than you should


    If you take too many tablets, contact your doctor or the nearest hospital emergency department immediately.


    If you forget to take RILUTEK


    If you forget to take your tablet, leave out that dose completely and take the next tablet at the usual time.

    Do not take a double dose to make up for a forgotten tablet.


    If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

  4. Possible side effects


    Like all medicines, this medicine can cause side effects, although not everybody gets them.


    IMPORTANT

    Tell your doctor immediately

    • if you experience any fever (increase in temperature) because RILUTEK may cause a decrease in the number of white blood cells. Your doctor may want to take a blood sample to check the number of white blood cells, which are important in fighting infections.


    • if you experience any of the following symptoms: yellowing of your skin or the white of your eyes (jaundice), itching all over, feeling sick, being sick, as this may be signs of liver disease (hepatitis).Your doctor may do regular blood tests while you are taking RILUTEK to make sure that this does not occur.


    • if you experience cough or difficulties in breathing, as this may be a sign of lung disease (called interstitial lung disease).


      Other side effects

      Very common side effects (may affect more than 1 in 10 people) of RILUTEK are:

    • tiredness

    • feeling sick

    • increased blood levels of some enzymes of the liver (transaminases).


      Common side effects (may affect up to 1 in 10 people) of RILUTEK are:

      - dizziness

      - numbness or tingling of the mouth

      - vomiting

      - sleepiness

      - increase in heartbeat

      - diarrhoea

      - headache

      - abdominal pain

      - pain


      Uncommon side effects (may affect up to 1 in 100 people) of RILUTEK are:

    • anaemia

    • allergic reactions

    • inflammation of the pancreas (pancreatitis).


      Reporting of side effects

      image

      If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


  5. How to store RILUTEK


    Keep this medicine out of the sight and reach of children.


    Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP. The expiry date refers to the last day of that month.


    This medicine does not require any special storage conditions.

  6. Contents of the pack and other information What RILUTEK contains

Core: anhydrous dibasic calcium phosphate, micro crystalline cellulose, anhydrous colloidal silica, magnesium stearate, croscarmellose sodium;

Coating: hypromellose, macrogol 6000, titanium dioxide (E171).


What RILUTEK looks like and content of the pack


The tablets are film-coated, capsule-shaped and white. Each tablet contains 50 mg of riluzole and is engraved with “RPR 202” on one side.

RILUTEK is available in a pack of 56 tablets to be taken orally.


Marketing Authorisation Holder

Sanofi Mature IP 54 rue La Boétie 75008 Paris France


Manufacturer

Opella Healthcare International SAS 56, Route de Choisy

60200 Compiègne France


For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.


België/Belgique/ Belgien

Sanofi Belgium

Tél/Tel: +32 (0)2 710 54 00

Lietuva

Swixx Biopharma UAB

Tel: +370 5 236 91 40


България

Swixx Biopharma EOOD

Тел.: +359 (0)2 4942 480

Luxembourg/Luxemburg

Sanofi Belgium

Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)


Česká republika sanofi-aventis, s.r.o. Tel: +420 233 086 111

Magyarország

SANOFI-AVENTIS Zrt.

Tel.: +36 1 505 0050


Danmark

Sanofi A/S

Tlf: +45 45 16 70 00

Malta

Sanofi S.r.l.

Tel: +39 02 39394275


Deutschland

Sanofi-Aventis Deutschland GmbH Tel: +49 (0)180 2 222010

Nederland

Genzyme Europe B.V. Tel: +31 20 245 4000


Eesti

Swixx Biopharma OÜ Tel: +372 640 10 30

Norge

sanofi-aventis Norge AS Tlf: +47 67 10 71 00

Ελλάδα

sanofi-aventis AEBE

Τηλ: +30 210 900 16 00

Österreich

sanofi-aventis GmbH Tel: +43 1 80 185 – 0


España

sanofi-aventis, S.A. Tel: +34 93 485 94 00

Polska

sanofi-aventis Sp. z o.o. Tel.: +48 22 280 00 00


France

sanofi-aventis France Tél : 0 800 222 555

Appel depuis l’étranger : +33 1 57 63 23 23

Portugal

Sanofi - Produtos Farmacêuticos, Lda. Tel: +351 21 35 89 400


Hrvatska

Swixx Biopharma d.o.o. Tel: +385 1 2078 500

România

Sanofi Romania SRL Tel: +40 (0) 21 317 31 36


Ireland

sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 00

Slovenija

Swixx Biopharma d.o.o. Tel: +386 1 235 51 00


Ísland

Vistor hf.

Sími: +354 535 7000

Slovenská republika Swixx Biopharma s.r.o. Tel: +421 2 208 33 600


Italia

Sanofi S.r.l.

Tel: 800 536389

Suomi/Finland

Sanofi Oy

Puh/Tel: +358 (0) 201 200 300


Κύπρος

C.A. Papaellinas Ltd.

Τηλ: +357 22 741741

Sverige

Sanofi AB

Tel: +46 (0)8 634 50 00


Latvija

Swixx Biopharma SIA Tel: +371 6 616 47 50

United Kingdom (Northern Ireland) sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44 (0) 800 035 2525


This leaflet was last approved in {MM/YYYY}.